A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

Clinical trial NCT07623161 · RECRUITING

Trial details

NCT number: NCT07623161
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myelofibrosis Anemia

Start date: 2026-08-25
Primary completion: 2029-12-07
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.